Clinical Trial Update: Added Value of PET/CT in Assessment of Hepatocellular Malignancy Post Radiofrequency Ablation

View source ↗

Summary

A completed clinical trial evaluated whether PET/CT improves assessment of hepatocellular carcinoma after radiofrequency ablation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Tanta University | Conditions: PET/CT, Hepatocellular Malignancy | Status: COMPLETED